U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C27H42O3
Molecular Weight 414.6206
Optical Activity ( + )
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ONTERNABEZ

SMILES

CCCCCCC(C)(C)C1=CC(OC)=C([C@H]2C=C(CO)[C@H]3C[C@@H]2C3(C)C)C(OC)=C1

InChI

InChIKey=CFMRIVODIXTERW-BDTNDASRSA-N
InChI=1S/C27H42O3/c1-8-9-10-11-12-26(2,3)19-14-23(29-6)25(24(15-19)30-7)20-13-18(17-28)21-16-22(20)27(21,4)5/h13-15,20-22,28H,8-12,16-17H2,1-7H3/t20-,21+,22-/m0/s1

HIDE SMILES / InChI

Description
Curator's Comment: The description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/20218623 | https://www.ncbi.nlm.nih.gov/pubmed/16407142 | https://www.ncbi.nlm.nih.gov/pubmed/27634891

HU-308 ([(1R,2R,5R)-2-[2,6-dimethoxy-4-(2-methyloctan-2-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl]methanol) is a potent, selective agonist for the CB2 receptor. The synthesis and characterization took place in the laboratory of Prof. Mechoulam at the Hebrew University of Jerusalem in the late 1990s. It has analgesic effects, promotes proliferation of neural stem cells,[3] and protects both liver and blood vessel tissues against oxidative stress via inhibition of TNF-α. In vivo, HU-308 has hypotensive, analgesic, and anti-inflammatory activities in mice that can be reversed by the CB2 receptor antagonist SR 144528 but not the CB1 receptor antagonist rimonabant. Pretreatment of mice with HU-308 decreases the I/R-induced tissue damage, inflammatory cell infiltration, tissue, and serum TNF-α, MIP-1, and MIP-2 levels, tissue lipid peroxidation, and apoptosis. HU-308 increases proliferation of HT29 colon cancer cells and growth of tumors in an HT29 mouse xenograft model. The physiological and toxicological properties of this compound have not been evaluated in humans.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor.
1999 Dec 7
Subunit-specific modulation of glycine receptors by cannabinoids and N-arachidonyl-glycine.
2008 Oct 15
Patents

Patents

Sample Use Guides

Rats were treated with HU-308 (0.3-30 mg/kg i.p.)
Route of Administration: Intraperitoneal
Cells were set up 4x103 cells per well of a 96-well plate and were cultured in DMEM medium supplemented with 10% FCS overnight. The medium was replaced for serum-free DMEM medium and cells were incubated for 48h with HU-308 (0.001, 0.01, 0.1, 1 and 10mkM). Cell viability was assayed by Cell Counting Kit-8 (CCK-8).
Name Type Language
ONTERNABEZ
INN  
Official Name English
BICYCLO(3.1.1)HEPT-2-ENE-2-METHANOL, 4-(4-(1,1-DIMETHYLHEPTYL)-2,6-DIMETHOXYPHENYL)-6,6-DIMETHYL-, (1S,4S,5S)-
Systematic Name English
PPP-003
Code English
onternabez [INN]
Common Name English
ARD-S003
Code English
ARDS003
Code English
(+)-HU-308
Common Name English
ONTERNABEZ [USAN]
Common Name English
(1S,4S,5S)-4-(4-(1,1-DIMETHYLHEPTYL)-2,6-DIMETHOXYPHENYL)-6,6-DIMETHYLBICYCLO(3.1.1)HEPT-2-ENE-2-METHANOL
Systematic Name English
HU-308
Common Name English
Classification Tree Code System Code
WIKIPEDIA Designer-drugs-HU-308
Created by admin on Fri Dec 15 16:42:38 UTC 2023 , Edited by admin on Fri Dec 15 16:42:38 UTC 2023
FDA ORPHAN DRUG 734920
Created by admin on Fri Dec 15 16:42:38 UTC 2023 , Edited by admin on Fri Dec 15 16:42:38 UTC 2023
Code System Code Type Description
SMS_ID
300000025391
Created by admin on Fri Dec 15 16:42:38 UTC 2023 , Edited by admin on Fri Dec 15 16:42:38 UTC 2023
PRIMARY
INN
11976
Created by admin on Fri Dec 15 16:42:38 UTC 2023 , Edited by admin on Fri Dec 15 16:42:38 UTC 2023
PRIMARY
PUBCHEM
11553430
Created by admin on Fri Dec 15 16:42:38 UTC 2023 , Edited by admin on Fri Dec 15 16:42:38 UTC 2023
PRIMARY
CAS
256934-39-1
Created by admin on Fri Dec 15 16:42:38 UTC 2023 , Edited by admin on Fri Dec 15 16:42:38 UTC 2023
PRIMARY
NCI_THESAURUS
C184881
Created by admin on Fri Dec 15 16:42:38 UTC 2023 , Edited by admin on Fri Dec 15 16:42:38 UTC 2023
PRIMARY
FDA UNII
8I5L034D55
Created by admin on Fri Dec 15 16:42:38 UTC 2023 , Edited by admin on Fri Dec 15 16:42:38 UTC 2023
PRIMARY
USAN
KL-18
Created by admin on Fri Dec 15 16:42:38 UTC 2023 , Edited by admin on Fri Dec 15 16:42:38 UTC 2023
PRIMARY
WIKIPEDIA
HU-308
Created by admin on Fri Dec 15 16:42:38 UTC 2023 , Edited by admin on Fri Dec 15 16:42:38 UTC 2023
PRIMARY
EPA CompTox
DTXSID801017327
Created by admin on Fri Dec 15 16:42:38 UTC 2023 , Edited by admin on Fri Dec 15 16:42:38 UTC 2023
PRIMARY